Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
about
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaquesA 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemicsRecreational and occupational field exposure to freshwater cyanobacteria--a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessmentAssessing healthcare utilization for influenza-like Illness at an emergency department and a student health service during the 2009-2010 H1N1 pandemicEntry of parainfluenza virus into cells as a target for interrupting childhood respiratory diseaseFactors that make an infectious disease outbreak controllableDengue virus pathogenesis: an integrated viewGenomic analysis of increased host immune and cell death responses induced by 1918 influenza virusLaboratory diagnosis of SARSCrossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledgeViral kinetic modeling: state of the artHost gene targets for novel influenza therapies elucidated by high-throughput RNA interference screensPathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaquesEarly responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virusMacrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumoniaPreclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineSerum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcomeInnate immunity to influenza virus: implications for future therapyThiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational levelAberrant innate immune response in lethal infection of macaques with the 1918 influenza virusInhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorNatural killer cells in infection and inflammation of the lungNeuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadImpact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsUsing Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.Exploring cell tropism as a possible contributor to influenza infection severityStrategies for containing an emerging influenza pandemic in Southeast AsiaHealth and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling studyTime and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniaeVirulence attenuation during an influenza A/H5N1 pandemicTwo years after pandemic influenza A/2009/H1N1: what have we learned?A systematic review to identify areas of enhancements of pandemic simulation models for operational use at provincial and local levels.Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningA Role for Neutrophils in Viral Respiratory Disease.The pathogenesis of influenza in humans.Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in miceNon-pharmaceutical interventions for pandemic influenza, international measures.
P2860
Q21090889-F1391B16-A538-41BC-9106-1DF1186B7870Q21245278-9A06DE80-99BB-4B38-9FDD-B11834803AD5Q21245823-6AD233DC-B56C-4057-9771-5D0D929157E5Q23909287-7B409FD4-CB8E-4DCE-9548-731DAB0C5521Q24530163-89808A8A-FD78-4E2B-9A18-BB243F168853Q24568031-3C125458-21E4-4D17-ACCA-4CE946941B20Q24645380-C7AF3D74-386C-4C6E-B0E0-BE5C139F5FAFQ24652550-AA0F66BF-415A-458E-B4E2-A905EEC17BA4Q24675259-0172254A-0336-45AF-8568-D7B7BA927AF9Q26824525-E37D7BEC-C833-4E48-9CCC-72C5FD107751Q26824655-55B55BD5-38AF-4440-B7F6-5416697A4448Q26852062-633F9814-73C9-479C-BE6A-FA9EBC953596Q27305046-25AD05D9-A9E4-4417-907A-5181E73ABF4FQ27322383-C7F437FC-74D8-4110-8665-93FD875C99DBQ27336255-2FDB2E34-6CD7-4479-BD8B-E7DB61CE5AF6Q27347652-FD5E0E46-55C1-427C-BF01-C778BB93E5FCQ27486417-C21A6C85-D5CA-4F1B-87C0-D3B1EE985CC9Q27489605-252F35A7-002D-404B-BC5C-5E36AA640054Q28253220-D7A8FDD2-B56D-4774-909C-8A3FBBE51AEEQ28283850-B0A39F83-07A6-4249-8132-9E77D22958E6Q28344143-314B7B4E-361F-4C6C-AAF1-9D2AD04FB1C1Q28391714-5E5B3444-5E45-4107-BA5F-8864796BC7F0Q28471814-3900424E-B2AD-4EEE-B4EC-A145D25CE491Q28472846-36619D6B-855D-466F-9428-67B92916880FQ28474889-637EE8E9-8392-4905-9195-15165F35ABCCQ28552030-F8558BB0-645A-49A2-AC8E-06DB4F2AE70DQ28748187-5E45293E-E76F-4188-81D3-73DE847C38D7Q29618561-6751D58E-8279-4E93-B1A9-BA2E6AF104C2Q30210097-C5B1CF4B-B066-4D44-9A43-D3526F048FCCQ30222430-8F5AE776-9B86-475A-9874-A471CA5CCCC2Q30223401-250CB562-6B4F-4399-8275-B4396D0EBF8DQ30224656-5F719CD1-109A-41D9-BA5C-1EA4B95ED398Q30224678-9DFFF55B-EC85-4B98-BCEE-5A4E66162E27Q30226457-1462E169-3FF4-4726-B699-0942BC0A7300Q30229485-8F29CBA9-708E-4797-A309-D8407CDBDEF2Q30230076-3C109005-DA74-4019-9929-25E4CC351F59Q30234336-F8C9AF8B-322E-4757-833C-2F489AA54914Q30328490-C18FC37A-9C80-423F-A70B-4261CA1D5F39Q30351800-8D14B13C-5974-4907-8E15-269B19A36DF6Q30353075-F2C0B4B5-116C-4B65-BA39-2C0C056D82A3
P2860
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Local and systemic cytokine re ...... tom formation and host defense
@ast
Local and systemic cytokine re ...... tom formation and host defense
@en
type
label
Local and systemic cytokine re ...... tom formation and host defense
@ast
Local and systemic cytokine re ...... tom formation and host defense
@en
prefLabel
Local and systemic cytokine re ...... tom formation and host defense
@ast
Local and systemic cytokine re ...... tom formation and host defense
@en
P2093
P2860
P356
P1476
Local and systemic cytokine re ...... tom formation and host defense
@en
P2093
P2860
P304
P356
10.1172/JCI1355
P407
P577
1998-02-01T00:00:00Z